GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (CHIX:MITRAb) » Definitions » Market Cap

Mithra Pharmaceuticals (CHIX:MITRAB) Market Cap : €14.45 Mil (As of May. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mithra Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Mithra Pharmaceuticals's share price for the quarter that ended in Jun. 2023 was €3.815. Mithra Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 58.59 Mil. Therefore, Mithra Pharmaceuticals's market cap for the quarter that ended in Jun. 2023 was €223.51 Mil.

Mithra Pharmaceuticals's quarterly market cap declined from Jun. 2022 (€418.82 Mil) to Dec. 2022 (€196.26 Mil) but then increased from Dec. 2022 (€196.26 Mil) to Jun. 2023 (€223.51 Mil).

Mithra Pharmaceuticals's annual market cap increased from Dec. 2020 (€847.45 Mil) to Dec. 2021 (€940.50 Mil) but then declined from Dec. 2021 (€940.50 Mil) to Dec. 2022 (€196.26 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Mithra Pharmaceuticals's Enterprise Value for Today is €198.50 Mil.


Mithra Pharmaceuticals Market Cap Historical Data

The historical data trend for Mithra Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Market Cap Chart

Mithra Pharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 754.67 1,029.20 847.45 940.50 196.26

Mithra Pharmaceuticals Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 896.61 940.50 418.82 196.26 223.51

Competitive Comparison of Mithra Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Mithra Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mithra Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mithra Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Mithra Pharmaceuticals's Market Cap falls into.



Mithra Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Mithra Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=€3.485*56.315
=€196.26

Mithra Pharmaceuticals's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )=Share Price (Q: Jun. 2023 )*Shares Outstanding (EOP) (Q: Jun. 2023 )
=€3.815*58.5871
=€223.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mithra Pharmaceuticals  (CHIX:MITRAb) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Mithra Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Mithra Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Mithra Pharmaceuticals (CHIX:MITRAB) Business Description

Traded in Other Exchanges
Address
Rue Saint-Georges 5, Liege, BEL, 4000
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (CHIX:MITRAB) Headlines

No Headlines